These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 4005851)
1. Specificity and inducibility of the metabolic reduction of chromium(VI) mutagenicity by subcellular fractions of rat tissues. Petrilli FL; Camoirano A; Bennicelli C; Zanacchi P; Astengo M; De Flora S Cancer Res; 1985 Jul; 45(7):3179-87. PubMed ID: 4005851 [TBL] [Abstract][Full Text] [Related]
2. Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity. De Flora S; Morelli A; Basso C; Romano M; Serra D; De Flora A Cancer Res; 1985 Jul; 45(7):3188-96. PubMed ID: 4005852 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary metabolism of mutagens and its relationship with lung cancer and smoking habits. De Flora S; Petruzzelli S; Camoirano A; Bennicelli C; Romano M; Rindi M; Ghelarducci L; Giuntini C Cancer Res; 1987 Sep; 47(17):4740-5. PubMed ID: 3621172 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of mutagens and carcinogens in woodchuck liver and its relationship with hepatitis virus infection. De Flora S; Camoirano A; Romano M; Astengo M; Cesarone CF; Millman I Cancer Res; 1987 Aug; 47(15):4052-8. PubMed ID: 3607750 [TBL] [Abstract][Full Text] [Related]
5. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine. Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854 [TBL] [Abstract][Full Text] [Related]
6. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds. De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042 [TBL] [Abstract][Full Text] [Related]
7. Metabolic activation and deactivation of mutagens and carcinogens. De Flora S Ital J Biochem; 1979; 28(2):81-103. PubMed ID: 399955 [TBL] [Abstract][Full Text] [Related]
8. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of cytochrome P450-inducers on promutagen activation capabilities and enzymatic activities of S-9 from rat liver. Ong T; Mukhtar M; Wolf CR; Zeiger E J Environ Pathol Toxicol; 1980 Aug; 4(1):55-65. PubMed ID: 7441130 [TBL] [Abstract][Full Text] [Related]
10. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450. Hales BF Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774 [TBL] [Abstract][Full Text] [Related]
11. Selective induction of gene expression in rat lung by hexavalent chromium. Izzotti A; Cartiglia C; Balansky R; D'Agostini F; Longobardi M; De Flora S Mol Carcinog; 2002 Oct; 35(2):75-84. PubMed ID: 12325037 [TBL] [Abstract][Full Text] [Related]
12. Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/beta-naphthoflavone or aroclor 1254 induced rat S-9. Johnson TE; Umbenhauer DR; Galloway SM Environ Mol Mutagen; 1996; 28(1):51-9. PubMed ID: 8698047 [TBL] [Abstract][Full Text] [Related]
13. Enzyme specificity in the metabolic activation of N-nitrosodimethylamine to a mutagen for Chinese hamster V79 cells. Yoo JS; Yang CS Cancer Res; 1985 Nov; 45(11 Pt 1):5569-74. PubMed ID: 4053031 [TBL] [Abstract][Full Text] [Related]
14. Chromium(VI)-induced DNA lesions and chromium distribution in rat kidney, liver, and lung. Tsapakos MJ; Hampton TH; Wetterhahn KE Cancer Res; 1983 Dec; 43(12 Pt 1):5662-7. PubMed ID: 6640521 [TBL] [Abstract][Full Text] [Related]
15. Metabolic reduction of chromium by alveolar macrophages and its relationships to cigarette smoke. Petrilli FL; Rossi GA; Camoirano A; Romano M; Serra D; Bennicelli C; De Flora A; De Flora S J Clin Invest; 1986 Jun; 77(6):1917-24. PubMed ID: 2423559 [TBL] [Abstract][Full Text] [Related]
16. In vitro effects of N-acetylcysteine on the mutagenicity of direct-acting compounds and procarcinogens. De Flora S; Bennicelli C; Zanacchi P; Camoirano A; Morelli A; De Flora A Carcinogenesis; 1984 Apr; 5(4):505-10. PubMed ID: 6368036 [TBL] [Abstract][Full Text] [Related]
17. Reduction of chromium(VI) to chromium(V) by rat liver cytosolic and microsomal fractions: is DT-diaphorase involved? Aiyar J; De Flora S; Wetterhahn KE Carcinogenesis; 1992 Jul; 13(7):1159-66. PubMed ID: 1379126 [TBL] [Abstract][Full Text] [Related]
18. Oral chromium(VI) does not affect the frequency of micronuclei in hematopoietic cells of adult mice and of transplacentally exposed fetuses. De Flora S; Iltcheva M; Balansky RM Mutat Res; 2006 Nov; 610(1-2):38-47. PubMed ID: 16872865 [TBL] [Abstract][Full Text] [Related]
19. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation. Buckpitt AR; Bahnson LS; Franklin RB J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983 [TBL] [Abstract][Full Text] [Related]
20. Binding of chromium to chromatin and DNA from liver and kidney of rats treated with sodium dichromate and chromium(III) chloride in vivo. Cupo DY; Wetterhahn KE Cancer Res; 1985 Mar; 45(3):1146-51. PubMed ID: 2578874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]